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Abstract 
Frailty is a complex of symptoms that is characterized by impaired stress tolerance 
due to a decline in the functionality of different organs. Due to its multifactorial 
aetiology, several definitions and assessments of this symptom complex have been 
developed, of which the Fried Frailty Score (Phenotype Score) and the broader 
Frailty Index (Deficit Accumulation Index) are the most commonly used. The 
prevalence of frailty increases with age independently of the assessment instrument 
and ranges between 4% and 59% in community-dwelling elderly populations and is 
higher in women than in men. The actual prevalence rate in a population depends on 
the prevalence of chronic diseases including depression, nutritional status, and 
inherently socio-economic background and education. Frailty is, however, not a 
steady state and progression, but also reversion is common. Although numerous 
studies on the prevalence of frailty have been conducted, systematic assessments in 
different populations are rare, which reduces the comparability of results. Similarly 
heterogeneous, but less frequent are studies on the incidence and on trajectories 
and transitions of frailty, calling for further, more systematic studies on this topic. 
  
Frailty is a complex of symptoms that is characterized by impaired stress tolerance 
due to a decline in the functionality of different organs because of sarcopenia, 
nutritional deficiencies, hormonal changes, and increased inflammation (1, 2). 
Though not a disease in itself, it is associated with an increased risk of falls, 
disability, hospitalization, institutionalization, and finally mortality (2, 3). 
There is no uniform definition of the frailty symptom complex. However, most studies 
are based on the definition introduced by Fried and colleagues (2), which includes 
unintentional weight loss, self-reported exhaustion, poor grip strength, slow walking 
speed, or low physical activity (2). This model is also called the Phenotype Model (4). 
Individuals are usually considered as frail if they meet at least 3 of the 5 criteria and 
as prefrail if they meet 1 or 2 of these criteria. This definition has a focus on the 
physical aspects of frailty. A more complex score, the so-called Frailty Index (or 
Frailty Index of Deficit Accumulation), was established by Mitnitski and colleagues (5) 
based on the proportion of 20 deficits observed in a structured clinical examination. 
These deficits include diseases, signs, symptoms, laboratory abnormalities, cognitive 
impairments, and disabilities in activities of daily living (6). Other definitions exist, but 




The prevalence of frailty has been assessed in many studies worldwide, although 
most studies were conducted in Western countries.  
One of the most comprehensive reviews on the epidemiology of frailty included 21 
community-based studies with 61,500 persons 65+ years old (7). Overall, the 
prevalence of frailty varied from 4.0% to 59.1% with an overall weighted prevalence 
of frailty of 10.7% (95% confidence interval (CI) 10.5-10.9). Of the 21 studies 
included, 14 used the Fried Frailty Score (2). A difference in the prevalence of frailty 
between studies emerged when studies were stratified by the assessment for frailty 
(7). In studies that assessed physical frailty, using e. g. the Fried Frailty Score, the 
prevalence rate ranged between 4.0% and 17.0%, but between 4.2% and 59.1% in 
studies that used broad definitions or measurement instruments (covering physical, 
but also social and psychological aspects for frailty). The weighted prevalence rate 
was 9.9% for physical frailty (95% CI 9.6-10.2; based on 15 studies with 44,894 
participants) and 13.6% for the broad phenotype of frailty (95% CI 13.2-14.0; based 
on 8 studies with 24,072 participants). 
Another review explicitly included only studies that used the Fried Frailty Score to 
assess the prevalence of frailty in community-dwelling individuals 65 years of age 
and older (8). In the six studies included, the prevalence of frailty ranged between 
4.9% in Taiwan and 27.3% in Spain. The Survey of Health, Aging and Retirement in 
Europe (SHARE; (9)) assessed frailty in a uniform way in Europe and still yielded 
vastly different prevalence rates across Europe. Generally, they observed a 
prevalence of 17%, with lows of 5.8% in Switzerland and 8.6% in Sweden and a high 
prevalence rate of 23% in Italy and 27.3% in Spain. The prevalence rates of prefrailty 
were more comparable between the single countries with 46.5% in Switzerland, 
45.3% in Sweden, 43.6% in Italy, and 50.9% in Spain.  
Geographic variation 
There is some indication that the prevalence of frailty and the extent of frailty is 
higher in poorer than in countries that are more affluent. A secondary analysis of the 
SHARE survey, which included more than 35,000 participants at least 50 years old 
from 15 countries, observed a lower mean frailty index in higher-income countries 
than in lower-income countries (10). The overall mean frailty index was inversely 
correlated with both gross domestic product (r = −0.79; P < 0.01) and health 
expenditure (r = −0.63; P < 0.05). The prevalence of frailty was lower in higher-
income countries compared with lower-income countries (16.1 versus 27.6%; P < 
0.01). Interestingly, survival in non-frail participants 2 years after baseline 
assessment was not associated with national income, but survival in frail people was 
significantly better in higher-income countries (10). One explanation for the higher 
prevalence of frailty in Southern compared with Northern countries participating in the 
SHARE study might be the lower rates of institutionalization of older disabled persons 
in southern countries, leading to a higher prevalence of frailty in community-based 
studies. 
In a systematic review of 47 studies that included community-dwelling adults 60+ 
years old in low- and middle-income countries, the pooled prevalence rate of frailty 
was 17.4% (95% CI 14.4%-20.7%) (11).This is higher than the overall weighted 
prevalence of frailty of 10.7% (95% CI 10.5-10.9) in 21 studies from high-income 
countries (7). The prevalence rates of frailty varied between 3.9% in China and 
51.4% in Cuba; the prevalence of prefrailty ranged from 13.4% in Tanzania to 71.6% 
in Brazil (11). However, only one low-income country (Tanzania) and one low-middle 
income country were included in that analysis; all other studies were conducted in 
high-middle income countries. The prevalence prefrailty was 49.3% (95% CI 46.4%-
52.2%) in low- and middle-income countries (11), which was also higher than the 
pooled rate of 41.6% (95% CI 41.2%-42.0%) in high-income countries (7). 
 
It is interesting to note that even studies conducted in the same country do not 
always provide similar estimates. The FRALLE survey, conducted in the Spanish city 
of Lleida, reported a frailty prevalence of 9.6% in participants 75+ years old (5.2% in 
men and 12.5% in women; (12)), but other Spanish studies provided prevalence 
rates ranging from 10.3% to 20.1% (see (12)). In the US, the prevalence reported 
was also very disparate, ranging from 6.9% in the study by Fried et al. (2001) to 
19.5% in the study among Mexican-Americans (13). A study looking at racial 
differences in the US observed that 8.7% of African-American men and 15.0% of 
African-American women were frail compared with 4.6% and 6.8% of white men and 
women, respectively (14). In adjusted models, taking age, sex, comorbidity, and 
socioeconomic factors into account, non-obese African Americans had fourfold 
greater odds of frailty compared with whites. This study also noted that the increased 
odds of frailty associated with African-American race was less pronounced among 
those who were obese or disabled. This study shows that, although socio-economic 
factor might play an important role, there may be other factors that play a role in the 
development of frailty. Large ranges were also reported from LMIC. A systematic 
review reported that the prevalence rate of frailty in community-dwelling older people 
ranged between 17% and 31% in Brazil, between 5% and 31% in China, and from 
21% to 44% in Russia, with all studies using the Fried Frailty Score (15). 
A Chinese study that included individuals of 60+ years used the physical frailty 
phenotype scale and reported a frailty prevalence of 7%, which ranged between 
3.3% and 9.1% depending on the study region (16). It was higher in rural than in 
urban areas and, as other studies had shown before, frail individuals were more likely 
to have co-morbidities and functional limitations than non-frail individuals were. 
 
Incidence 
Incidence studies on frailty are rare; most studies only describe the prevalence in a 
certain population. In the Cardiovascular Health Study, which included 5,317 
participants 65 years and older, the four-year incidence was 7.4% (2). In an analysis 
of the longitudinal Osteoarthritis Initiative (OAI) database with 4421 study 
participants, the incidence of frailty amounted to 12 (95% CI 10–14) participants per 
1000 person-years (17). In an analysis of the Progetto Veneto Anziani, which 
included 1887 individuals older than 65 years of age and free of frailty at baseline, 
21.9% had become frail after an observation period of 4.4 years (18). These results 
illustrate the problems with respect to information on frailty incidence from 
longitudinal studies. Even if numbers of incident frailty cases are reported, it is 
difficult to compute incidence rates due to the lack of information on person-time. 
Moreover, hardly any study used age-standardization to make studies comparable. 
This was illustrated in a systematic review by Galluzzo et al. (19). Only 3 of the 6 
studies included had the aim of estimating frailty incidence, with a wide age-range of 
participants. The incidence proportion ranged from 5% (follow-up 22.2 years; age ≥ 
30 years) to 13% (follow-up 1 year, age ≥ 55 years). Looking only at studies that 
used the Fried Frailty Score and were conducted on relatively similar samples in 
terms of age, the incidence proportions ranged from 3.9% for a follow-up of about 3 
years to about 8% over periods from 3.5 to 9.9 years. The highest incidence rate was 
observed in an Australian study that included remotely living aboriginal people. 
Participants were 45+ years old, and of those who were non-frail at the beginning of 
the study, 51.5% became frail during the 7-year follow-up period (20). 
 
Reasons for differences in the prevalence of frailty between populations 
Differences due to different assessment instruments 
The definition of frailty varies from physical disability, impairment in basic or 
instrumental activities of daily living to an increased vulnerability to adverse 
outcomes. In a review, Buta et al. identified 67 frailty instruments that were 
mentioned in scientific publication, of which nine were highly-cited (≥200 citations) 
(21). The Physical Frailty Phenotype, as introduced by Fried et al., was the most 
frequently used frailty instrument in the research literature, followed by the Deficit 
Accumulation Index and the Vulnerable Elders Survey. The definition by Fried et al. 
focuses on a wasting syndrome, with weight loss and negative energy balance as 
important elements (2). Other criteria have emphasized a life course approach, taking 
into account mid- and early-life influences on late-life frailty. Cognitive and social 
factors for improving the prediction of frailty are a more-recent research focus (21). 
For example, a US study among 6000 community-dwelling elderly adults (65-95 
years old) showed that including cognitive impairment as a variable improved the 
predictive validity of the operational definition of frailty (22). Another study conducted 
among 744 70+ year old community-dwelling individuals concluded that slow gait 
speed, low physical activity, weight loss, and cognitive impairment were key 
indicators of frailty, but questioned the usefulness of self-reported exhaustion and 
muscle weakness (23). 
Collard et al. (7) showed in their meta-analysis that the differences in frailty 
prevalence rates were less diverse when assessments based on the physical frailty 
definition were used compared with a broader definition that also covers social and 
psychosocial aspects. The smaller range of frailty rates in the first group of studies 
might imply more consensus in the definition of frailty between researchers or a more 
reliable definition. The advantage is a better comparability of studies. If a broad frailty 
definition is used, it appears to be very important to examine separately the different 
aspects within the respective frailty definition. This will provide more information 
about who needs special care in specific domains, but may also enhance the 
understanding and disentangling of underlying pathophysiological processes of 
frailty. 
 
Differences due to different operationalizations of the single components of the 
instrument 
The Fried Frailty Score basically assesses slow walking, weak grip strength, low 
physical activity, exhaustion, and weight loss (2). However, depending on the 
concrete assessment of these five variables, the prevalence rate might differ even 
though the same definition has been used. This has been studied and discussed in 
the SHARE study. Criteria used to define frailty in the SHARE study were not 
identical to those used in the Cardiovascular Health Study, except for weakness, and 
may be less specific, leading to higher estimates of the prevalence particularly for 
exhaustion, which was common in the SHARE population (9). In a follow-up on this 
issue, Romero-Ortuno showed in detail how the categorization of study participants 
changed depending on how the five variables of the Fried Frailty Score were defined 
(24).  
 
Differences due to different settings 
The prevalence rates differ substantially depending on the setting where they have 
been conducted. Prevalence rates are substantially lower among community-dwelling 
individuals compared with institutionalized individuals living, e. g., in nursing homes. 
The review by Nguyen revealed a prevalence of frailty of 49% in institutionalized 
older patients in Brazil and 32% in hospitalized older patients in India. The 
prevalence of frailty in outpatient clinics was 55%-71% in Brazil and 28% in Peru 
(15). As mentioned above, this may also differ between countries or regions, 
depending, for example, on whether older people are more likely to stay at home or 
with family member rather than living at nursery homes. This leads to lower or higher 
proportions of frail elderly in the community-dwelling population (10). 
 
Risk factors 
A systematic review evaluated factors that were either risk or protective factors for 
frailty (25). In total, 23 longitudinal studies with community-dwelling individuals 60+ 
years old were included. Statistically significant associations with frailty were 
observed for sociodemographic factors (7/7 studies; this included older age, ethnic 
background, neighbourhood, and access to private insurance or Medicare), physical 
factors (5/6 studies; obesity and activities of daily living functional status), biological 
factors (5/7 studies; serum uric acid), lifestyle factors (11/13 studies; higher Diet 
Quality Index International score, higher fruit/vegetable consumption and higher 
tertile of all measures of habitual dietary resveratrol exposure), and psychological 
factors (7/8 studies; depressive symptoms). Many more factors have been analysed 
in these studies, but most of them either did not turn out to be significantly associated 
with frailty or were examined in only a small number of studies (25). The study 
among Australian aboriginal people clearly supports a multifactorial aetiology, 
including on the one hand underlying chronic diseases and on the other hand 
psychosocial stressors (20). 
 
Age and sex seem to be clearly associated with frailty. In the meta-analysis by 
Collard et al., the prevalence increased with age and was higher in women (9.6%, 
95% CI 9.2-10.0%) than in men (5.2%, 95% CI 4.9-5.5%) (2). In the SHARE survey, 
at all ages, the mean frailty index was greater in women than in men regardless of 
country. Every additional year of age was associated with a 3.5 and 2.8% higher 
mean frailty index in lower- and higher-income countries, respectively (10). The 
difference by sex and the increase with age are seen in high- (7) as well as in low- 
and middle-income countries (11). The prevalence of frailty is higher in women 
compared to men because women have lower average amounts of lean body mass 
and muscle strength (2).  
A systematic review and meta-analysis by Verlaan et al. (26) assessed the 
prevalence of malnutrition and frailty among community-dwelling elderly, the 
prevalence of frailty ranged between 0% (a study in Taiwan) and 36.6% (in a 
Lebanese study). Pooling data from ten studies using comparable assessment 
instruments, the authors observed that the prevalence of physical frailty was higher 
among those with less favourable nutritional status such that 68.0% were frail in the 
malnourished group, but only 11.9% in the well-nourished group (as assessed using 
the Mini-Nutritional Assessment) (26). However, vice versa, the association was less 
clear. A prevalence rate of 0.5% malnutrition was observed in the robust group and 
8.4% in the frail group. 
 
Frailty Progression 
So far, only few studies examined the progression of frailty. Most studies are cross-
sectional in nature and do not observe changes over time. However, frailty is not a 
steady state. In a follow-up of the SHARE study that included individuals 55+ years 
old, frailty worsened in 22.1% of the participants within two years after the first 
assessment, remained stable in 61.8% of the participants and improved in 16.1% 
(27). The risk of worsening increased with age and was statistically significantly 
higher in individuals 65+ years old at baseline assessment, in women and in 
individuals with low education. It is interesting that participants from Southern 
European countries (France, Italy and Greece) had an increased risk of worsening at 
an earlier age compared with those in Northern and middle European countries 
(Sweden, Denmark, Germany, the Netherlands, and Switzerland). Also, although 
there was an overall higher risk among women for worsening of symptoms compared 
with men, no sex differences were found in Northern European countries, whereas 
women were at increased risk of worsening in frailty state compared with men in 
Southern European countries and in Belgium. A systematic review of three studies 
concluded that studies on frailty trajectories are rare and the results, as for 
prevalence and incidence rates, highly heterogeneous and dependent on the 
population and the setting (28). 
 
Conclusion 
In summary, frailty is widely spread in the elderly population worldwide. Depending 
on the instrument that was used to determine frailty, the calculated prevalence will 
vary. Studies have shown that prevalence rates are more comparable when the 
physical frailty index as defined by Fried and colleagues is used than a broader 
definition that also covers social and psychosocial aspects. However, not only the 
instrument used, but also geographic variation has been observed independent of 
the assessment instrument. Prevalence rates in the community-dwelling population 
tend to be higher in lower-income countries compared with higher-income countries 
and one of the underlying reasons might be that in lower-income countries fewer 
older, and potentially frail, people live in nurseries than in higher-income countries. 
Contributing to differences between studies are different proportions of men and 
women and different age distributions. Other factors, such as nutritional status, 
depression, but also ethnic background, are important. Few studies have, however, 
been conducted on the progression of frailty. Although it has been shown that frailty 
status of individuals may improve, it is currently unclear who is more likely to improve 
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